INIS
amplification
100%
losses
100%
patients
100%
hearings
100%
interventions
42%
risks
21%
data
14%
inclusions
14%
comparative evaluations
14%
management
14%
therapy
14%
control
7%
noise
7%
acoustics
7%
reviews
7%
devices
7%
inventories
7%
stimulation
7%
quality of life
7%
adults
7%
symptoms
7%
throat
7%
nose
7%
ears
7%
Nursing and Health Professions
Hearing Impairment
100%
Sensory Aid
100%
Tinnitus
100%
Generator
11%
Epileptic Absence
11%
CINAHL
5%
Medline
5%
Quality of Life
5%
Cochrane Library
5%
Medical Device
5%
Randomization
5%
Clinical Management
5%
Symptom
5%
Confidence Interval
5%
Adverse Event
5%
Base
5%
Auditory Stimulation
5%
Disability
5%
Placebo
5%
Visual Analog Scale
5%
Throat Disease
5%
Nose Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hearing Impairment
100%
Tinnitus
100%
Randomized Controlled Trial
23%
Epileptic Absence
11%
Placebo
5%
Group Trial
5%
Symptom
5%
Base
5%
Adverse Event
5%
Disability
5%
Throat Disease
5%
Nose Disease
5%
Neuroscience
Tinnitus
100%
Sensation of Hearing
100%
Randomized Controlled Trial
23%
Epileptic Absence
11%
Nose
5%
Placebo
5%